GlassScriptPhysician profile
Russell B Baker
NPI 1760043822
$26,818.43
in general payments reported to CMS, 2019-2025
25 companies · $5,377 in 2025
The $5,377 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2020: $144 · 2021: $1,574 · 2022: $10K · 2023: $4,486 · 2024: $4,619 · 2025: $5,377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,518 · Travel and Lodging: $6,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,517.73 |
| Travel and Lodging | $6,964.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $15,136.98 | 2022-2025 | Augment Injectable, Inbone, Infinity |
| Alpha Orthopedic Systems | $3,996.56 | 2021-2023 | |
| Treace Medical Concepts, INC. | $1,558.08 | 2022-2025 | |
| Smith+Nephew, INC. | $1,441.02 | 2019-2025 | Stravix, Grafix Pl, Oasis |
| Arthrex, INC. | $1,317.50 | 2022-2023 | |
| Paragon 28, INC. | $1,061.87 | 2023-2024 | Monkey Rings, Portfolio, Grappler |
| International Life Sciences | $728.83 | 2023 | |
| Acumed LLC | $350.04 | 2020-2023 | Acumed |
| Horizon Therapeutics Plc | $247.11 | 2022-2023 | Krystexxa |
| Polynovo North America LLC | $236.30 | 2023-2024 | Novosorb Btm |
| Acera Surgical, INC. | $200.47 | 2023-2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $108.15 | 2025 | Minibunion |
| Bioventus LLC | $103.11 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Baxter Healthcare | $83.67 | 2024 | Tisseel |
| Urgo Medical North America, LLC | $32.68 | 2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Surgical LLC | $30.91 | 2025 | |
| Abbvie INC. | $30.90 | 2024 | |
| Medtronic, INC. | $30.79 | 2024-2025 | Minimed 780g |
| Kci USA, INC. | $25.66 | 2022 | |
| Medline Industries LP | $18.36 | 2024 | Medline |
| Organogenesis INC. | $18.05 | 2023 | Puraply |
| Novo Nordisk INC | $16.97 | 2025 | Ozempic, Rybelsus |
| Allergan, INC. | $16.32 | 2020 | |
| Xeris Pharmaceuticals, INC. | $14.46 | 2024 | Gvoke Hypopen |
| Kowa Pharmaceuticals America, INC. | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.